The Human Autoantibody Response to Apolipoprotein A-I Is Focused on the C-Terminal Helix: A New Rationale for Diagnosis and Treatment of Cardiovascular Disease?
作者： Sabrina Pagano , Hubert Gaertner , Fabrice Cerini , Tiphaine Mannic , Nathalie Satta
DOI: 10.1371/JOURNAL.PONE.0132780
关键词:
摘要: Cardiovascular disease (CVD) is the leading cause of death worldwide and new approaches for both diagnosis treatment are required. Autoantibodies directed against apolipoprotein A-I (ApoA-I) represent promising biomarkers use in risk stratification CVD may also play a direct role pathogenesis.
harvard.edu
paperity.org参考文章(38)
P.-F. Keller, S. Pagano, P. Roux-Lombard, P. Sigaud, O. T. Rutschmann, F. Mach, D. Hochstrasser, N. Vuilleumier, Autoantibodies against apolipoprotein A‐1 and phosphorylcholine for diagnosis of non‐ST‐segment elevation myocardial infarction Journal of Internal Medicine. ,vol. 271, pp. 451- 462 ,(2012) , 10.1111/J.1365-2796.2011.02479.X
S. Pagano, N. Satta, D. Werling, V. Offord, P. de Moerloose, E. Charbonney, D. Hochstrasser, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 IgG in patients with myocardial infarction promotes inflammation through TLR2/CD14 complex. Journal of Internal Medicine. ,vol. 272, pp. 344- 357 ,(2012) , 10.1111/J.1365-2796.2012.02530.X
Madeleine W. Cunningham, Streptococcus and rheumatic fever. Current Opinion in Rheumatology. ,vol. 24, pp. 408- 416 ,(2012) , 10.1097/BOR.0B013E32835461D3
Steven A. Kates, Nuria A. Solé, Charles R. Johnson, Derek Hudson, George Barany, Fernando Albericio, A novel, convenient, three-dimensional orthogonal strategy for solid-phase synthesis of cyclic peptides Tetrahedron Letters. ,vol. 34, pp. 1549- 1552 ,(1993) , 10.1016/0040-4039(93)85003-F
W. Sean Davidson, Thomas B. Thompson, The Structure of Apolipoprotein A-I in High Density Lipoproteins Journal of Biological Chemistry. ,vol. 282, pp. 22249- 22253 ,(2007) , 10.1074/JBC.R700014200
A R Dinu, J T Merrill, C Shen, I V Antonov, B L Myones, R G Lahita, Frequency of antibodies to the cholesterol transport protein apolipoprotein A1 in patients with SLE. Lupus. ,vol. 7, pp. 355- 360 ,(1998) , 10.1191/096120398678920262
LeAnne T. Bloedon, Richard Dunbar, Danielle Duffy, Paula Pinell-Salles, Robert Norris, Bruce J. DeGroot, Rajesh Movva, Mohamad Navab, Alan M. Fogelman, Daniel J. Rader, Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients Journal of Lipid Research. ,vol. 49, pp. 1344- 1352 ,(2008) , 10.1194/JLR.P800003-JLR200
John W. Taylor, The synthesis and study of side‐chain lactam‐bridged peptides Biopolymers. ,vol. 66, pp. 49- 75 ,(2002) , 10.1002/BIP.10203
J. R. BATUCA, P. R. J. AMES, D. A. ISENBERG, J. DELGADO ALVES, Antibodies toward high-density lipoprotein components inhibit paraoxonase activity in patients with systemic lupus erythematosus. Annals of the New York Academy of Sciences. ,vol. 1108, pp. 137- 146 ,(2007) , 10.1196/ANNALS.1422.016
P. A. Wick, A. Mombelli, S. Pagano, X. Moren, C. Giannopoulou, F. Mach, P. Roux-Lombard, N. Vuilleumier, Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis Journal of Periodontal Research. ,vol. 48, pp. 350- 356 ,(2013) , 10.1111/JRE.12014